Element Biosciences unveiled Vitari, a high‑throughput sequencing platform the company says can generate 3 terabytes per paired‑end 150 bp run in 36 hours and sequence a 30X human genome for $100. The platform targets large‑scale genomics centers and clinical labs seeking to cut per‑sample cost and turnaround time. Element positions Vitari as a direct challenge to entrenched incumbents by combining claimed throughput, speed and economics. Analysts note adoption will hinge on real‑world run metrics, reagent costs, and bioinformatics support; clinical and regulatory validation will determine whether the $100 genome claim translates into routine clinical use.